FAPI-mFS
CAT:
804-HY-164725-02
Size:
5 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No
FAPI-mFS
- CAS Number: 3023869-94-2
- UNSPSC Description: FAPI-mFS is an irreversible fibroblast activation protein (FAP) inhibitor, that enhances the uptake and retention time in cancer cells through its covalent binding property for FAP. FAPI-mFS can be used for cancer imaging the therapy, when labeled with radioactive 68Ga or 177Lu[1].
- Target Antigen: FAP; Radionuclide-Drug Conjugates (RDCs)
- Type: Peptides
- Related Pathways: Antibody-drug Conjugate/ADC Related;Immunology/Inflammation
- Applications: Cancer-programmed cell death
- Field of Research: Cancer
- Assay Protocol: https://www.medchemexpress.com/fapi-mfs.html
- Solubility: DMSO : ≥ 100 mg/mL
- Smiles: O=C(N[C@H](C(N1CCN(CCCOC2=CC=C(N=CC=C3C(NCC(N4[C@H](C#N)CC(F)(F)C4)=O)=O)C3=C2)CC1)=O)CCCCNC(C5=CC(OS(F)(=O)=O)=CC=C5)=O)CN6CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC6
- Molecular Weight: 1203.25
- References & Citations: [1]Cui XY, et al., Covalent targeted radioligands potentiate radionuclide therapy. Nature. 2024 Jun;630(8015):206-213.
- Shipping Conditions: Blue Ice
- Clinical Information: No Development Reported